Symbiox Investment & Trading C
Latest filings
- Quarterly compliance filing on share dematerialization for Q2 FY26 · Compliance
- BSE seeks clarification on significant price movement · Regulatory & Legal
- 47th AGM voting results: Both resolutions passed with 99.98 percent approval · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates in the investment and trading space, with a balance sheet of Rs 31.976 crore in total assets as of FY26. The company earns revenue from its investment and trading activities — Rs 1.6029 crore in FY26, producing a net profit of Rs 0.1505 crore. Quarterly income is highly uneven, with Q3 FY26 at Rs 8.60 lakh versus Rs 77.56 lakh in the year-ago quarter, indicating lumpy, transaction-driven realizations rather than a recurring income stream. The cost base is small, with employee costs at 12.8% of revenue and other operating expenses at 12.0%, while materials and capex are negligible. Equity stands at Rs 3,187.63 lakh, almost the entire Rs 3,197.60 lakh asset base. The filings do not detail what specific instruments or assets the company invests in or trades; they confirm only that the entity operates in this space.
Scorecard
Measured from the filed financials, judged against its Other Financial Services peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from Symbiox Investment & Trading C's filed financials and exchange disclosures
What does Symbiox Investment & Trading C do?
Symbiox Investment & Trading C is a Finance company listed on BSE.
Is Symbiox Investment & Trading C profitable?
Yes. Over the trailing twelve months Symbiox Investment & Trading C reported a net profit of ₹0.16 Cr on revenue of ₹1.40 Cr.
Does Symbiox Investment & Trading C pay a dividend?
Not in the latest reported year — Symbiox Investment & Trading C's dividend payout for FY26 was nil.
Is Symbiox Investment & Trading C debt-free?
Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.27 Cr of cash.
Is Symbiox Investment & Trading C expensive compared with its peers?
On trailing P/E, Symbiox Investment & Trading C ranks 48 of 76 in Other Financial Services — cheaper than 37% of them, against an industry median of 19.0×. This is a position, not a valuation judgement.
How much does the Symbiox Investment & Trading C share price move in a day?
On a typical session Symbiox Investment & Trading C moves 3.00% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track Symbiox Investment & Trading C's announcements?
Every NSE and BSE filing by Symbiox Investment & Trading C appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.